Statement of Principles concerning malignant neoplasm of the oral cavity, oropharynx and hypopharynx (Balance of Probabilities) (No. 66 of 2021)

Disease definition and exclusions - The SoP defines malignant neoplasm of the oral cavity, oropharynx and hypopharynx as a primary malignancy of the mucosa in the specified region. The exclusion of salivary gland tumours and lymphomas is grounded in histopathological and aetiological differences: those cancers have distinct risk factors and latency periods. The definition also excludes the vermilion border and skin of the lips, which are keratinising squamous epithelium with different UV and tobacco exposure risks. Death from the disease includes a terminal event contributed to by the malignancy, with “terminal event” defined in the dictionary to include pneumonia, respiratory failure, cardiac arrest, circulatory failure, or cessation of brain function.

Balance of probabilities standard - The instrument is made under subsection 196B(3) of the VEA, which governs SoPs for claims assessed on the balance of probabilities. This standard requires that a factor be more probable than not (greater than 50 per cent) causal. It is distinct from the “reasonable hypothesis” standard applied to operational service claims under section 120(1) of the VEA. Claimants with operational service may still have a claim assessed under this SoP if they are proceeding under section 120B (non-operational service) or section 339 of the MRCA (peacetime service). The instrument is therefore not a blanket for all veterans; it only covers those with “relevant service” as defined.

Relevant service - The dictionary defines relevant service as: (a) eligible war service (other than operational service) under the VEA; (b) defence service (other than hazardous service and British nuclear test defence service) under the VEA; or (c) peacetime service under the MRCA. This excludes service that is classified as operational, hazardous, or British nuclear test defence service. Such exclusions likely reflect the different statutory standards applicable to those service categories and the possibility that separate SoPs or different proof standards apply.

Key quantitative thresholds - The instrument imposes specific dose thresholds for lifestyle and environmental factors. Smoking requires at least five pack-years, with the standard pack-year calculation (20 cigarettes per day for one year, or 7,300 grams of smoking tobacco by weight). Second-hand smoke requires at least 10,000 hours of exposure in an enclosed space - roughly equivalent to 1.14 years of continuous exposure, though in practice must be accumulated over a longer period. Alcohol requires a total of at least 100 kilograms within any ten-year period, which equates to 10,000 standard drinks (at 10 grams per drink) or on average about 2.74 standard drinks per day. The ten-year window here is not continuous but within any ten-year period, allowing some flexibility for episodic heavy drinking.

Cessation windows - For most factors, if the exposure ceased before clinical onset, the onset must have occurred within a specified timeframe: ten years for smoking, second-hand smoke, smokeless tobacco, betel quid/areca nut, and maté; forty years for alcohol; for HPV and HIV, there is no cessation window because these are persistent infections. The forty-year window for alcohol is unusually long, meaning a veteran could have stopped drinking heavily decades before diagnosis and still satisfy the factor. This may reflect the prolonged latency of alcohol-related carcinogenesis or the difficulty of proving cumulative dose over a lifetime.

Factor exclusivity for oral cavity - Factors 10 (specified list of oral lesions) and 11 (oral lesions caused by systemic lupus erythematosus) apply only to malignant neoplasm of the oral cavity, not to oropharynx or hypopharynx. The specified list includes erythroplakia, leukoplakia, lichen planus, oral lichenoid lesions, oral submucous fibrosis, and proliferative verrucous leukoplakia. These are known precursor or associated lesions, but their presence must be for at least one year before clinical onset.

Cross-reference to other SoPs - Section 11 provides that if a factor in this SoP refers to an injury or disease covered by another SoP, the factors in that other SoP apply. For example, “infection with human immunodeficiency virus” might be covered by a separate SoP for HIV, which would need to be satisfied to prove the infection is related to service. This prevents overlapping SoPs from creating conflicting criteria.

The SoP directly affects veterans, members of the Forces, and MRCA members who claim compensation for malignant neoplasm of the oral cavity, oropharynx or hypopharynx under the VEA or MRCA, where the claim is assessed on the balance of probabilities. Because the instrument defines “relevant service” to exclude operational service, hazardous service, and British nuclear test defence service, a significant proportion of veterans who served in combat or hazardous roles will not have their claims assessed under this SoP unless they can bring their claim under a non-operational service provision (e.g., service classified as eligible war service but not operational). This creates an incentive for claimants and their representatives to establish that the service giving rise to the exposure falls within the relevant service definition.

The instrument also affects the Repatriation Commission and the Military Rehabilitation and Compensation Commission as decision-makers, who must apply the factors strictly. It imposes a compliance burden on those bodies to verify each element of the chosen factor: pack-years, hours of exposure, grams of alcohol, biopsy-proven HPV infection, immunosuppressive drug history, and the like. For claimants, the burden lies in proving these facts, often decades after the events. The evidentiary requirements are high: smoking history may rely on self-reporting or service records; second-hand smoke exposure must be documented in enclosed spaces (workplaces, ships, barracks); alcohol intake may be partially documented through medical records or self-report.

Legal practitioners, advocates, and advisory bodies (such as the Department of Veterans’ Affairs and the Veterans’ Review Board) must interpret and apply the SoP. The detailed definitions of terms such as “pack-year” and “having been exposed to second-hand smoke” are subject to textual analysis, and disputes about the application of the cease-to-once window periods are likely. The instrument does not affect civilians, private health insurers, or the general healthcare system, except indirectly through its impact on compensation budgets.

From an economic perspective, the SoP concentrates benefits (compensation payouts) on a defined group of claimants while costs are borne by the consolidated revenue (taxpayers). Because the SoP sets relatively low thresholds for some factors (e.g., five pack-years is a comparatively modest smoking history) and long cessation windows (e.g., forty years for alcohol), it expands the number of eligible claims compared to a stricter regime. This creates a moral hazard in that service personnel have no direct incentive to avoid risk factors such as smoking and heavy drinking, since compensation may be available later. However, service conditions themselves (e.g., stress, availability of cigarettes, social drinking) may have influenced behaviour. The instrument does not address the counterfactual: whether the disease would have occurred in the absence of service, given that many factors are common in the general population.

The SoP does not create new duties or rights directly; rather, it specifies the conditions under which a statutory right to compensation arises. The relevant right is found in sections 120B and 196B of the VEA and section 339 of the MRCA: the right to have a claim determined, and the right to have that determination apply a SoP where one exists. The SoP binds decision-makers: if a claimant satisfies at least one factor in section 9, and that factor is related to relevant service, the decision-maker must find that the disease is service-related on the balance of probabilities. The instrument thus converts a question of medical causation into a legal presumption, provided the claimant meets the listed criteria.

Claimants have the right to submit evidence of any factor, not just tobacco or alcohol. The instrument does not rank factors or require primary reliance on any one. A claimant could rely on betel quid chewing even if they also smoked. However, the burden of proof lies on the claimant to demonstrate the existence of the factor and its relationship to service. The decision-maker’s duty is to apply the instrument as a legislative rule, not as a clinical guideline. There is no room for medical discretion once the facts are established - if the facts fit the factor, the connection is deemed.

Factor 12 (inability to obtain appropriate clinical management) is a significant exception. It only applies where the disease was already present before or during service (but did not arise out of service) and the lack of appropriate clinical management materially contributed to the progression or aggravation of the disease. This imposes a duty on the decision-maker to assess whether the claimant received timely and adequate treatment during service. If the disease was first diagnosed after discharge, factor 12 is likely not available.

Section 10 requires that each factor be related to the person’s relevant service. This is not a separate burden but an integral element: the claimant must show, for example, that the smoking occurred during service or that the alcohol consumption was service-related (e.g., due to conditions of service). A veteran who smoked only before enlistment cannot rely on factor 1 unless the smoking is related to service, which would be unlikely. This creates an evidentiary burden to link the exposure to the service period.

Section 11 gives rights and duties regarding other SoPs. If a factor (e.g., HIV infection) is itself covered by another SoP, the claimant must also satisfy the factors in that SoP to establish that factor is related to service. This means a claim may require compliance with multiple SoPs, increasing complexity and cost for claimants and decision-makers alike.

The SoP itself contains no penalties or enforcement mechanisms. It is an administrative instrument that guides decision-making, not a regulatory code with sanctions. Enforcement, if that term can be used, occurs through the internal review and external review process. A claimant who is dissatisfied with a decision can seek review by the Veterans’ Review Board, the Administrative Appeals Tribunal, and ultimately the Federal Court on questions of law. The SoP is a legislative instrument subject to judicial review; if a decision-maker misapplies the factors (for example, miscalculating pack-years or misinterpreting the cessation window), the decision can be set aside.

There are no criminal penalties or civil fines for failing to comply with the SoP. However, making a false statement in support of a claim (e.g., fabricating a smoking history or second-hand smoke exposure) would be an offence under the Criminal Code or the VEA itself, but those penalties are not part of this instrument. Similarly, a decision-maker who knowingly applies the SoP incorrectly could face administrative sanctions, but again those arise from general law or codes of conduct, not from this SoP.

The practical enforcement mechanism is the cost of delay and litigation. Claimants bear the cost of gathering evidence and challenging adverse decisions. The State bears the cost of administering claims and defending review applications. This asymmetric cost structure can deter claimants with borderline cases, even if the SoP factors would technically support them. Conversely, it can encourage strategic behaviour where claimants inflate exposure histories because precise documentation is lacking.

The instrument does not provide for any penalties for non-compliance by third parties, such as employers or medical practitioners who fail to provide records. It simply assumes that the facts can be established. Where evidence is unavailable or ambiguous, the decision maker must still apply the balance of probabilities - but if evidence is insufficient, the claim will be rejected. Thus the SoP functions as a de facto evidentiary checklist, and the “penalty” for inadequate evidence is denial of compensation.

The SoP is made under the VEA and operates within the broader legislative framework for military compensation. It directly interacts with:

• VEA sections 120B and 196B: These are the enabling provisions. Section 120B specifies that where a SoP exists, a claim cannot succeed unless the material before the decision-maker raises a connection that fits the SoP factors. This SoP is such a SoP, so any claim for malignant neoplasm of the oral cavity, oropharynx or hypopharynx under the VEA (on a balance-of-probabilities basis) must be assessed against it.

• MRCA section 339: This mirrors section 120B for MRCA claims. The SoP applies to claims under that provision as well. Thus the same factors apply to peacetime service under the MRCA.

• Other Statements of Principles (SoPs): Section 11 explicitly provides for cross-reference. For example, if a claimant relies on HIV infection, the factors in the SoP for HIV (if any) must also be satisfied. This prevents inconsistent medical evidence and ensures that the causal link between the infection and service is established under the same standard.

• The Safety, Rehabilitation and Compensation Act 1988 (SRCA): This Act governs workers’ compensation for Commonwealth employees, including some defence personnel not covered by the VEA or MRCA. The SoP may be relevant in SRCA claims for similar diseases, but it is not directly binding unless the SRCA or its regulations adopt it. The source does not discuss this link, so we note only that it may be used as evidence.

• State workers’ compensation: The SoP has no direct application to state schemes, which have their own medical guidelines. However, a veteran who also has a state workers’ compensation claim may rely on the SoP as evidence of causation, but the state scheme is not bound by it.

• Tort law: For negligence claims against the Department of Defence or other parties, the SoP is not binding but could be used as expert evidence on medical causation. Courts are not required to apply the factors.

• Immigration and Border Protection: Not relevant.

The instrument also interacts with the common law standard of proof. Under the VEA, for operational service claims the standard is reasonable hypothesis, which is lower than balance of probabilities. If a claimant has both operational and non-operational service, they may elect which to rely on. A claim that fails under this SoP (balance of probabilities) might still succeed under the reasonable hypothesis standard, which does not require a SoP to be satisfied in the same way.

From a free-market perspective, the interaction with other compensation systems can produce overlapping or contradictory incentivess. For example, a veteran may pursue a VEA claim based on this SoP while also claiming from a private income protection insurer. The insurer will assess causation independently, potentially leading to inconsistent outcomes. The SoP thus creates a specific evidentiary regime that may not align with general insurance or tort standards.

The source contains limited amendment history. The instrument is a new SoP that repeals the earlier Statement of Principles concerning malignant neoplasm of the oral cavity, oropharynx and hypopharynx No. 2 of 2013 (F2013L00017). The earlier instrument was made under the same enabling provision (subsection 196B(3) of the VEA) but is replaced as of 21 June 2021. No further amendments to this instrument are shown in the source; it appears as a single, consolidated instrument.

The Explanatory Statement that typically accompanies a SoP would detail the changes, but it is not included in the source provided. Without that document, we cannot specify what changed in the factors or definitions. However, we can note that the RMA periodically reviews SoPs based on evolving medical evidence. The 2021 instrument may incorporate new research on the role of HPV, the dose-response for alcohol, or the latency periods for various factors. The inclusion of maté consumption (factor 5) and the specific ten-year latency for betel quid (factor 4) may be new or refined compared to 2013. The very long forty-year cessation window for alcohol (factor 6) may have been extended or introduced. Similarly, the exclusion of salivary gland tumours and lymphomas may have been clarified.

The repeal of the 2013 SoP means that any claim decided after 21 June 2021 must be determined under the new instrument, even if the disease manifested earlier. Claims lodged before commencement but decided after might also be subject to the new instrument, depending on transitional provisions which are not contained in the source. The instrument does not include any savings or transitional clauses, which may create uncertainty for pending claims.

From a compliance and predictability standpoint, replacing SoPs creates a moving target for claimants and their representatives. The burden of understanding the exact criteria in force at the relevant time falls on the legal profession. The RMA does not conduct regulatory impact assessments for SoPs (they are exempt as quasi-judicial medical determinations), so the costs of adjusting to new thresholds are passed onto applicants.

The source itself does not contain any reference to litigation history. It is a legislative instrument, not a court judgment. However, as a general matter, Statements of Principles under the VEA have been the subject of extensive litigation in the Administrative Appeals Tribunal (AAT) and the Federal Court. Common grounds of challenge include: whether the RMA correctly interpreted the medical-scientific evidence; whether the definition of a factor is legally valid; whether the cessation windows are arbitrary; and whether the instrument unreasonably restricts the range of factors.

For example, the phrase “sound medical-scientific evidence” in section 196B(2) has been judicially considered. The Federal Court has held that the RMA has a broad discretion and that its determinations are not to be lightly set aside. However, if a SoP excludes a factor that is clearly supported by medical evidence, a claimant may argue that the SoP is invalid for unreasonableness. The specific exclusion of carcinoid tumours and lymphomas in this SoP could be challenged if evidence emerges linking those conditions to the same risk factors. The forty-year cessation window for alcohol might also attract judicial scrutiny as arguably too generous, but that would be a policy matter.

Given the absence of source, we can only note that the instrument is likely to be cited in AAT cases concerning oral cancer claims. The previous SoP (No. 2 of 2013) may have generated case law on, for example, what constitutes “having been exposed to second-hand smoke” in an enclosed space, or how to calculate pack-years for pipe tobacco. That case law would apply to the new instrument where definitions are unchanged. Claimants and practitioners should review the case law on the old SoP to anticipate how the new definitions will be interpreted.

The source does not list any court cases, so we cannot name any. This is a limitation; the deep dive can only state that litigation history is not provided.

Several features of this SoP contain traps for the unwary.

Factor 12 restricted to aggravation cases only. Subsection 10(2) makes it clear that factor 12 (inability to obtain appropriate clinical management) applies only to material contribution to, or aggravation of, a malignant neoplasm that was suffered or contracted before or during service but did not arise out of service. Many claimants mistakenly assume that a mere failure to diagnose during service will automatically entitle them to compensation under this factor. That is wrong: if the disease first appeared after discharge, factor 12 cannot be used. It only helps those whose disease existed during service and was worsened by inadequate treatment.

The second-hand smoke factor is narrower than it appears. The definition requires exposure in “an enclosed space” and inhalation of smoke from burning tobacco or exhaled smoke. Outdoor exposure, even if frequent, does not count. The 10,000-hour threshold is high (about 1.14 years of continuous 24/7 exposure, or about 4 years of 8-hour workdays). Claimants who were exposed to smoke in open-air messes or on deck ships may not satisfy this factor. The burden of proving enclosed-space exposure for that duration is substantial.

Alcohol cessation window of forty years is a double-edged sword. While it allows claimants who stopped drinking long before onset to still qualify, it also means that heavy drinking during service must be documented for a period that could be very old. The alcohol factor requires at least 100 kilograms within any ten-year period and onset at least five years after that period. A claimant who drank heavily in the 1970s but was diagnosed in 2020 can still rely on this factor, but they must prove the quantity of consumption four decades ago, which is often impossible without service records of purchase or medical notes.

Smoking pack-year threshold applies to the period before clinical onset, not before diagnosis. The factor uses “clinical onset” which may be earlier than formal diagnosis. Claimants must show the smoking occurred before the disease became clinically manifest. This can be a factual dispute when onset is unclear.

Exclusions for lymphoma and salivary gland cancer. A veteran with a malignant neoplasm in the oral region that turns out to be a non-Hodgkin lymphoma or a salivary gland tumour is not covered by this SoP at all. They must rely on separate SoPs for those conditions. This can result in a claim being rejected if the pathology report is ambiguous.

Relevant service excludes operational service. Many veterans with operational service will not have their claims considered under this SoP unless they can bring their claim under a non-operational basis (e.g., if the disease is connected to service that is not “operational”). The decision-maker must check the service classification. A veteran who served on operations might mistakenly assume this SoP covers them.

The definition of “specified list of oral lesions” (factor 10) is exhaustive. Only the six listed lesions count. Other potentially pre-cancerous lesions such as actinic cheilitis or oral hairy leukoplakia are not included. Claimants with those lesions cannot rely on factor 10.

Betel quid and areca nut - one per day for one year. The threshold is low, but the factor requires continuous use for at least one year and commencement at least ten years before onset. Many veterans from certain ethnic backgrounds may have chewed betel nut only intermittently; that will not satisfy “continuous period of at least 1 year of at least one per day”. Also, cessation must be within ten years of onset.

Immunosuppressive drugs for transplant only. Factor 9 requires taking an immunosuppressive drug for organ or tissue transplantation. It does not cover immunosuppressive therapy for autoimmune diseases (e.g., rheumatoid arthritis, Crohn’s disease, lupus) unless those diseases themselves involve a transplant. This is a narrow factor.

HPV infection - must be persistent infection of the oral cavity or oropharyngeal epithelium. A positive blood test for HPV antibodies or a cervical infection does not satisfy this factor. The infection must be at the site of the cancer, and it must be type 16 or 18. Proving persistent infection decades later is very difficult without archived tissue.

MBrains: The instrument does not consider synergistic effects. The factors are treated as independent. A claimant who smoked less than five pack-years but also drank heavily and had HPV may not satisfy any single factor even though combined exposures are clearly carcinogenic. The SoP does not allow combination of factors to reach a causal inference; each factor must be satisfied individually. This can result in denials of claims with strong cumulative evidence.

Compliance with this SoP means satisfying one of the factors in section 9 and proving its relationship to relevant service. For a claimant’s legal representative, the process is systematic:

1. Confirm eligibility - Verify that the claimant’s service falls within “relevant service” as defined: eligible war service (other than operational), defence service (other than hazardous or British nuclear test defence service), or peacetime service under the MRCA. If the claimant had operational service, the claim may need to be assessed under the reasonable hypothesis standard, not this SoP.

2. Obtain a precise diagnosis - Ensure the pathology report confirms a primary malignancy of the mucosa of the oral cavity, oropharynx or hypopharynx, and excludes the conditions listed in subsection 7(2)(b) (carcinoid, lymphomas, salivary gland tumours, soft tissue sarcoma). If the pathology is ambiguous, request a specialist review.

3. Establish the clinical onset date - This is critical because all factors have time windows measured from clinical onset. Onset may be the date of first symptoms or diagnosis, depending on the medical evidence. Document the chronology carefully.

4. Assess each factor - For each possible factor, gather all available records:

   • Smoking: service medical records, purchase records, unit canteen receipts, witness statements, self-reported history. Calculate pack-years using the formula.
   • Second-hand smoke: evidence of enclosed spaces (ship compartments, barracks, vehicles), duration, and frequency. Occupations such as aircraft mechanics or cooks in confined messes may be relevant.
   • Smokeless tobacco: service records of chewing tobacco use.
   • Betel quid/areca nut: if the claimant served in areas such as Papua New Guinea or Southeast Asia.
   • Maté: mainly for veterans who served in South America or returned migrants; may be less common.
   • Alcohol: medical records of alcohol-related admissions, incident reports, service disciplinary records, mess card records, self-reporting. Calculate total grams: 100 kilograms = 100,000 grams = 10,000 standard drinks. Document any ten-year period.
   • HPV: tissue biopsy from the tumour site positive for HPV-16 or -18 by PCR or in situ hybridisation, with evidence of persistence (not a one-off contact).
   • HIV: serology evidence from service or post-service.
   • Immunosuppressive drugs: transplant history and medication records.
   • Oral lesions (only for oral cavity): clinical photographs, biopsy reports of erythroplakia, leukoplakia, lichen planus, oral lichenoid lesions, oral submucous fibrosis, proliferative verrucous leukoplakia, present for at least one year before onset.
   • SLE-related oral lesions: specialist report confirming SLE diagnosis and oral lesions.

5. Prove relationship to service - For factor 12, show that the disease existed during service and that service hindered appropriate clinical management. For other factors, show that the exposure occurred during service (e.g., smoking while on active duty) or that the factor is attributable to service conditions (e.g., stress-induced heavy drinking). Mere presence of the factor in a civilian context will not suffice.

6. Check cessation windows - For each relevant factor, ensure that if the exposure stopped before clinical onset, the onset fell within the stated period after cessation (10 years for most; 40 years for alcohol). For factors with no cessation window (HPV, HIV, immunosuppressive drugs), the infection/treatment must have occurred before onset but can be remote.

7. Consider multiple factors - The claimant only needs one, but it is wise to plead all plausible factors to maximise the chance of success. If none are satisfied, consider whether a different SoP applies (e.g., for lymphoma) or whether the claim can be made under the reasonable hypothesis standard for operational service.

8. Prepare comprehensive supporting evidence - The SoP demands documentary proof. Affidavits alone are often insufficient for quantitative factors like pack-years or alcohol grams. Use contemporaneous records where possible. For old exposures, seek corroboration from unit mates, service records, and historical supply logs.

Decision-makers must follow the same steps in reverse: verify the diagnosis, check the factor, confirm the timing, and ensure the exposure is related to relevant service. There is no discretion to waive any threshold. The compliance burden is asymmetrical: claimants need high-quality historical evidence, which may be costly and stressful to assemble. The instrument does not lower that burden; it codifies it.